Medical Products Supplies Companies

9901 Belward Campus Drive, Suite 300, 20850 Rockville, MD
USA
Telephone +1 240 268-5400
Fax +1 240 268-1107
sales@tetracore.com
http://www.tetracore.com

Product Categories

Product categories

01 Electromedical Equipment / Medical Technology
01.01 Diagnostics
01.01.01 Equipment for audiological diagnostics

Equipment for audiological diagnostics

02 Laboratory Technology
02.01 Analyser systems / equipment

Analyser systems / equipment

03 Diagnostic Tests
03.02 Immunochemistry testing, immunology testing
03.02.02 Diagnostic rapid tests

Diagnostic rapid tests

RedLine Alert™
Recommended Live Organism for Positive Control
Recommended Live Organism for Negative Control

03 Diagnostic Tests
03.06 Genetic testing, molecular diagnostics
03.06.03 Polymerase chain reaction (PCR)

Polymerase chain reaction (PCR)
Our products

Product category: Diagnostic rapid tests
RedLine Alert™
RedLine Alert™ test.

Intended Use: The Tetracore RedLine Alert™ Test is an immunochromatographic test intended for the rapid, in vitro qualitative presumptive identification of Bacillus anthracis from non-hemolytic Bacillus colonies cultured on sheep blood agar plates. The test is intended for use in clinical, public health, and hospital laboratories in conjunction with other markers and testing for the presumptive identification of Bacillus anthracis.

Easy to use and easy to interpret so you can accelerate the “can’t rule out” process.

On a non-hemolytic Bacillus , if the RedLine Alert™ Test is positive, then B. anthracis can’t be ruled out. Submit the sample to the appropriate State Lab for confirmation.

RedLine Alert™ gives sentinel labs the ability to significantly shorten the time from when the plate is streaked until PCR confirmation is completed at the LRN reference lab.

Superior to gamma phage lysis when tested against 145 extremely well-characterized, independent, genetically and geographically diverse B. anthracis isolates, from 28 countries covering all major diversity groups: Ames-Sterne, Vollum, Western North America, Southern Africa, and Kruger.

RedLine Alert™ Test: 98.6% correct
Gamma Phage Lysis: 97.2% correct
The two false negative results with the RedLine Alert™ Test and the four false negative results with gamma phage lysis did not coincide, thus emphasizing that utilization of more than one detection method can aid in the identification of B. anthracis

No false positives (i.e. 100% correct negatives) test results with 49 non-hemolytic Bacillus spp, (other than B. anthracis).

Product category: Diagnostic rapid tests
Recommended Live Organism for Positive Control
To those users who desire to use a live, cultured organism as a positive control for the RedLine Alert (TM) test, in addition to or instead of the positive control antigen provided with the RedLine Alert kit, we recommend the use of B. anthracis Sterne strain.

Product category: Diagnostic rapid tests
Recommended Live Organism for Negative Control
To those users who desire to use a live, cultured organism as a negative control for the RedLine Alert (TM) test, we recommend the use of any non-hemolytic Bacillus species. Examples of acceptable strains of non-hemolytic Bacillus, readily available from ATCC, include the following:

B. megaterium ATCC 25833
B. megaterium ATCC 14581
B. circulans ATCC 7049
B. licheniformis ATCC 33632
B. coagulans ATCC 7050

ad: contact information

About Us

Company details
Tetracore is a biotechnology research and development organization that develops highly innovative kits, assays and reagents for the detection of infectious diseases, biological warfare (BW) threat agents and biological markers. The company focuses on antibody-based and nucleic acid-based detection reagents and technologies. Tetracore offers a broad range of highly-specific, rapid, antibody-based test kits and antibody reagents for the detection of BW infectious agents and toxins, including the first FDA cleared test kit for identification of B. anthracis from colonies. Tetracore also offers a product line of real-time, probe hydrolysis Polymerase Chain Reaction (PCR) tests for animal pathogens. In addition, Tetracore contracts with the US Government for development of: real-time PCR diagnostic tests for BW agents, novel nucleic acid extraction procedures, and specialized nucleic acid products.

The four founding scientists, Gary Long, Ph. D., Beverly L. Mangold, Ph.D.*, Thomas W. O’Brien, Ph.D., and William M. Nelson, M.D. (CDR, US Navy Ret.), have been leaders in the development of state-of-the-art diagnostic technology for use by the Joint Program Office for Bio-defense (JPO), the Department of Defense (DOD), FBI, and DOE. These scientists bring their extensive expertise and skills to Tetracore Inc. in order to provide these same organizations with an expanded production capability, greater flexibility in the development of new technology, and the ability to innovate in an entrepreneurial atmosphere.

Tetracore’s strong scientific team and powerful technology base positions the company at the forefront in the development and production of today’s important detection tools for Clinical, Animal Health, and Domestic Preparedness Testing.

ad: company